Add SPRAVATO® (esketamine) to Your Private Psychiatry Practice

Have you considered offering SPRAVATO® at your practice but unsure where to start? Watch an informative and educational webinar on how to expand your private practice. SPRAVATO®, also known as esketamine, is a viable and FDA-approved treatment option in the field of mental health. During this webinar, Dr. Carlene MacMillan and Brittainy Wagner provide an overview of SPRAVATO®, including its efficacy and practical guidelines for adding it to your practice. What you’ll learn: Overview of SPRAVATO®: efficacy, safety and side effects The business considerations such as billing, insurance coverage, and competitive differentiation Logistics involving set and setting How to navigate REMS program and the need for payers to see rating scales, similar to TMS, using Osmind With modality-specific workflows and streamlined REMS reporting in place via Osmind’s EHR, offering SPRAVATO® in your practice can be profitable and rewarding. It’s a win/win as it enables you to serve individuals using insurance who can’t afford other types of treatments out-of-pocket. Learn how to broaden your treatment offerings and provide more effective care to those who need it most.